Edit |   |
---|---|
Antigenic Specificity | CD152 (Lorigerlimab biosimilar) |
Clone | monoclonal |
Host Species | Recombinant |
Reactive Species | human |
Isotype | n/a |
Format | Protein A purified |
Size | 100 µg, 1 mg, |
Concentration | 1 mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | This product is for research use only (RUO) by laboratories. It is not suitable for use in humans or as a medicine. Lorigerlimab is a Chimeric Humanized monoclonal antibody targeting CD152, expressed in Mammalian cells. |
Immunogen | n/a |
Other Names | Lorigerlimab, Tetravalent Bispecific, CD152, Cytotoxic T-lymphocyte protein 4, CTLA-4, CTLA4, Cytotoxic T-lymphocyte-associated antigen 4, Programmed cell death protein 1, Protein PD-1, hPD-1, PD1, PDCD1, CD279 |
Gene, Accession # | UniProt: P16410, Q15116 |
Catalog # | abx832127 |
Price | please inquire |
Order / More Info | CD152 (Lorigerlimab biosimilar) Antibody from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950